Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double

Sales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.